SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global antifungal drugs market is estimated to be valued at US$ 11,591.0 Mn in 2020 and is expected to exhibit a CAGR of 1.8% during the forecast period (2020-2027).
Key Trends and Analysis of the Global Antifungal Drugs Market:
The increasing incidence of invasive candidiasis and vaginal candidiasis is expected to propel the global antifungal drugs market growth. The rising prevalence of invasive candidiasis, vaginal candidiasis, and preterm births poses high economic burden on the patient-population. For instance, according to the Centers for Disease Control and Prevention (CDC), candidemia, a form of invasive candidiasis, was one of the most common bloodstream infections in the U.S., with an average incidence of around 9 per 100,000 cases between 2013 and 2017.
Moreover, according to the same source, in 2017, around 84% of the total healthcare cost and 48% of the hospitalizations for candida infections was attributable to invasive candidiasis. The average cost per hospitalization for invasive candidiasis was around US$ 64,723 to US$ 153,090.
The increasing number of preterm births is expected to boost the market growth. For instance, according to the Kolling Institute of Medical Research published its result in 2015, that shows vaginal candidiasis can increase the risk of preterm births.
Moreover, according to a survey by researchers from the University of Miyazaki in 2017, the incidence of vulvovaginal candidiasis (VC) during pregnancy is 13 to 20% globally.
Furthermore, according to the Obstetric and Gynecology Department, Italy, 2018, VC is estimated to be the second most common cause of vaginitis and is found in 40% of women with vaginal discomfort. VC can cause systemic infections in premature neonates, particularly those with low birth weight.
Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/237
Key Market Takeaways:
The global antifungal drugs market is expected to exhibit a CAGR of 1.8% during the forecast period (2020-2027), owing to the increasing incidence of invasive candidiasis and vaginal candidiasis.
The growth of the North America antifungal drugs market is attributed to launches of antifungal drugs in the U.S.
Competitive Landscape:
Key players operating in the global antifungal drugs market are GlaxoSmithKline Plc, Bayer AG, Abbott Laboratories, Merck & Co., Inc, Glenmark Pharmaceuticals Limited, Enzon Pharmaceuticals, Inc., Pfizer Inc., Gilead Sciences, Inc., Sanofi S.A. and Astellas Pharma, Inc.
Buy-Now this Research report @ https://www.coherentmarketinsights.com/insight/buy-now/237
Market Segmentation:
-
Global Antifungal Drugs Market, By Drug Type:
- Polyenes
- Allylamines
- Azoles
- Others
-
Global Antifungal Drugs Market, By Indication:
- Aspergillosis
- Dermatophytosis
- Candidiasis
- Others
-
Global Antifungal Drugs Market, By Dosage Form:
- Powders
- Ointments
- Drugs
- Others
-
Global Antifungal Drugs Market, By Region:
-
North America
- U.S.
- Canada
-
Europe
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
-
Asia Pacific
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
-
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
-
Middle East
- GCC
- Israel
- Rest of Middle East
-
Africa
- South Africa
- Central Africa
- North Africa
-
North America
Related Market Intelligence Report:
Brain Health Supplements Market, by Product Type (Herbal Extracts {Ginseng, Ginkgo Biloba, Curcumin, Lions Mane, and Others}, Vitamins & Minerals {Vitamin B, Vitamin C & E, and Others}, and Natural Molecules {Acetyl-L-Carnitine, Alpha GPC, Citicoline, Docosahexaenoic Acid, and Others}), by Application (Memory Enhancement, Mood & Depression, Attention & Focus, Longevity & Anti-aging, Sleep & Recovery, and Anxiety), by Supplement Form (Tablets, Capsules, and Others), by Age Group (Geriatric, Adults, and Pediatrics), and by Distribution Channel (Supermarkets & Hypermarkets, Drug Stores, and Online Stores), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027
Read more: https://www.coherentmarketinsights.com/market-insight/brain-health-supplements-market-4205
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.
